News

23andMe struck a deal last month with Regeneron Pharmaceuticals Inc., but Wojcicki complained about the bidding process, ...
Regeneron founder, chairman and CEO Dr. Leonard Schleifer joins 'Squawk Box' to discuss the company's bid for 23andMe, ...
Me’s sale to Regeneron is not yet a done deal. The privacy ombudsman is scheduled to report on the privacy aspects of the ...
The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.
Me's Interim CEO Joe Selsavage said 1.9 million customers have asked the company delete their data since March.
Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...
A company like 23andMe can answer a lot of questions for an adoptee. But those answers come with a high cost to privacy.
House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer ...
Regeneron is backing away from buying the DNA-testing company after a nonprofit controlled by co-founder Wojcicki made a ...
Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...
The co-founder of bankrupt genetic analysis company 23andMe won an auction for the firm’s assets, agreeing, along with a ...
New York and 27 other states sued bankrupt genetic testing company 23andMe to block the sale of 15 million customers' ...